Arca
Skip to content
Tools
Tools

Beta-lactamase TEM

Protein in Bacteria that 6 drugs act on.

  • Drugs that act on it: 6
  • Approved: 6
  • In phases 1 to 3: 0
  • Sponsors: 5
  • Genes: 5

Who is on it, and how far along

Every drug ChEMBL records acting on BLA, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Small molecule 6

Approved6

  • Clavulanic acid
  • Tazobactam
  • Avibactam
  • Sulbactam
  • Enmetazobactam
  • Relebactam anhydrous

Phase 30

    Phase 20

      Phase 10

        Sponsors

        Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: Bacterial beta-lactamase TEM inhibitor.
        Clavulanic acidApprovedJohnson & JohnsonSmall moleculeInhibitor58
        TazobactamApprovedMerck & Co. (MSD)Small moleculeInhibitor51
        AvibactamApprovedWockhardtSmall moleculeInhibitor32
        SulbactamApprovedAnabio R&DSmall moleculeInhibitor22
        EnmetazobactamApprovedOrchid PharmaSmall moleculeInhibitor2
        Relebactam anhydrousApprovedMerck & Co. (MSD)Small moleculeInhibitor1

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 32 in all, from ClinicalTrials.gov.
        A Superiority Study of Model-Guided Optimized Dosing Versus Empirical Dosing of Piperacillin/Tazobactam in the Treatment of Community-Acquired Pneumonia in Elderly PatientsTazobactamPhase 2RecruitingShandong UniversityNov 18, 2026
        Prospective Randomized Trial Protocol for Duration of Post-Operative Tazocin Treatment After Whipple OperationTazobactamPhase 4RecruitingTel-Aviv Sourasky Medical CenterNov 16, 2026
        Probiotic Bifidobacterium Breve PRL2020 in Oral Drops in Preventing Side Effects From Amoxicillin or Amoxicillin/Clavulanic Acid Antibiotic UseClavulanic acidNot applicableNot yet recruitingLiaquat University of Medical & Health SciencesNov 13, 2026
        Safety Assessment of Placing a Single Dental Implant Without Antibiotic Prophylaxis in Simple Cases: A Pilot StudyClavulanic acidNot applicableNot yet recruitingUniversity of Medicine and Pharmacy at Ho Chi Minh CityNov 5, 2026
        Real-world Effectiveness of Cefiderocol Versus Aztreonam/AvibactamAvibactam—Active, not recruitingUniversity Hospital Virgen de las NievesNov 2, 2026
        Targeted Antimicrobial Comparison for Treatment Individualization in Critically Ill Patients With CRAB InfectionSulbactam—Not yet recruitingCentral South UniversityOct 29, 2026
        Antibiotic Tissue Penetration and Tissue Response in Head and Neck Infection and Reconstructive SurgeryClavulanic acidPhase 4RecruitingTejs Ehlers KlugOct 26, 2026
        Aztreonam-Avibactam in Immunocompromised HostsAvibactam—RecruitingCentro de Educación Medica e Investigaciones Clínicas Norberto QuirnoOct 22, 2026
        Cefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaAvibactamPhase 3Not yet recruitingWockhardtOct 21, 2026
        Amoxicillin-clavulanate Versus Amoxicillin Versus Placebo in Acute Otitis Media in ChildrenClavulanic acidPhase 4Not yet recruitingKuopio University HospitalOct 16, 2026
        Comparison of Topical Antibiotics Versus Systemic Antibiotics in Preventing Burn Wound Infection in Pediatric Burn PatientsClavulanic acidNot applicableNot yet recruitingabdul mateenOct 13, 2026
        Piperacillin/Tazobactam Versus Ceftriaxone and Metronidazole for Children With Perforated AppendicitisTazobactamPhase 3Not yet recruitingMcMaster Children's HospitalOct 9, 2026
        Patient Choice Between Antibiotics and Appendectomy in Uncomplicated Appendicitis (FRENCH 47 - ALACARTE)Clavulanic acidPhase 2Not yet recruitingAssistance Publique - Hôpitaux de ParisOct 5, 2026
        Prophylactic Antibiotic Duration in Head and Neck Cancer Surgery (PROTECT-HN Trial)SulbactamPhase 3RecruitingAC Camargo Cancer CenterOct 1, 2026
        This is a Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ertapenem-zidebactam Versus Ceftazidime-Avibactam in the Treatment of Hospitalized Adult Patients With Complicated Urinary Tract Infection or Acute PyelonephritisAvibactamPhase 2Not yet recruitingWockhardtSep 24, 2026
        Tissue Penetration of Antibiotics in CriTically Ill ChildrenClavulanic acid, Tazobactam—RecruitingUniversity Hospital, GhentSep 16, 2026
        Resistance-Optimised Antimicrobial Dosing in Critically Ill Patients, a Randomised Controlled TrialTazobactamNot applicableNot yet recruitingThe University of QueenslandSep 15, 2026
        Differentiating True Nephrotoxicity From Pseudo-nephrotoxicity: A Prospective Comparative Study of Vancomycin Plus Piperacillin-Tazobactam vs. Meropenem Using Serum Creatinine and Cystatin-CTazobactam—RecruitingKing Faisal Specialist Hospital & Research CenterSep 14, 2026
        Effectiveness of Saccharomyces Boulardii in Prevention of Antibiotic Associated DiarrheaClavulanic acidNot applicableNot yet recruitingUniversity of Child Health Sciences and Children's Hospital, LahoreAug 25, 2026
        Impact of Hypoalbuminemia on Cefoperazone/Sulbactam Induced Coagulopathy in Post-Operative Surgical PatientsSulbactam—Not yet recruitingSheikh Zayed Federal Postgraduate Medical InstituteAug 19, 2026
        Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver TransplantationAvibactam, Relebactam anhydrous, TazobactamPhase 3Not yet recruitingIRCCS Azienda Ospedaliero-Universitaria di BolognaAug 12, 2026
        Cefepime/Enmetazobactam for Bacteremic Complicated Urinary Tract InfectionsEnmetazobactam—Not yet recruitingIRCCS Azienda Ospedaliero-Universitaria di BolognaJul 24, 2026
        Ceftazidime-Avibactam PK/PD and Resistance in Hematology PatientsAvibactam—Not yet recruitingSizhou FengJul 14, 2026
        INterest of the Negative Predictive Value of Integrons in the reduCtion of Large Broad-spectrum anTibiotics Consumption for Urinary Tract infectionSTazobactamNot applicableRecruitingUniversity Hospital, LimogesJun 30, 2026
        Self-Start Triage Model for Post-Botox® Lower Urinary Tract SymptomsSulbactamEarly phase 1RecruitingThe Cleveland ClinicJun 15, 2026
        A Clinical Study of YK-1169 Versus Ceftazidime-Avibactam in Adults With Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaAvibactamPhase 3Not yet recruitingNanjing Yoko Biomedical Co., Ltd.Jun 8, 2026
        Sulbactam-Durlobactam in CRAB Infection: A Real-World Cohort StudySulbactam—RecruitingSichuan Provincial People's HospitalMay 22, 2026
        One Versus Five Days of Antibiotics After AppendectomySulbactamNot applicableNot yet recruitingMinistry of Health and Population, EgyptMay 4, 2026
        Individualized Precision Therapy With Ceftazidime and Avibactam Guided by PK/PD in Geriatric PopulationsAvibactam—Not yet recruitingChinese PLA General HospitalMar 27, 2026
        Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform TrialSulbactamPhase 2Not yet recruitingThe University of QueenslandMar 20, 2026
        Assessing Role of Probiotics in Children Aged 6-36 Months Treated for PneumoniaSulbactamNot applicableNot yet recruitingAnabio R&DFeb 10, 2026
        A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTIEnmetazobactamPhase 2RecruitingOrchid Pharma Europe GmbHApr 24, 2023

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364670, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.